-
Mashup Score: 2Pfizer to price COVID treatment Paxlovid at $1,390 per course - 7 month(s) ago
Pfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it.
Source: www.reuters.comCategories: General Medicine News, HIV/AIDSTweet
-
Mashup Score: 0Breaking Barriers in Urologic Research: Tackling Health Disparities and Collaborative Solutions - Cheryl T. Lee - 7 month(s) ago
Sam Washington and Cheryl Lee discuss the Challenges of Urologic Research Symposium, focusing on overcoming health disparities in urologic research. The conversation highlights the need to address health disparities through research and collaboration. They discuss various aspects, including the history of race in research, clinical and translational research, increasing representation in…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Breaking barriers in urologic research: Tackling #healthdisparities and collaborative solutions. @ctleeuro @OSUCCC_James and @SamWashUro @UCSFCancer emphasize the need for collaboration, investment, and resource utilization to reduce health disparities > https://t.co/Rht57CEfFT https://t.co/gYMGKFufcB
-
-
Mashup Score: 0Associations between race/ethnicity and SEER-CAHPS patient care experiences among female Medicare beneficiaries with breast cancer - 7 month(s) ago
We aimed to determine if racial/ethnic disparities exist in survivorship care patient experiences among older breast cancer survivors.
Source: www.geriatriconcology.netCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Addressing Health Care Disparities in Psoriasis - 7 month(s) ago
In her Dermatology Week Fall 2023 session, “Health Disparities in Dermatology: Psoriasis,” Dr Junko Takeshita underscored the critical issue of health care disparities in dermatology.
Source: www.hmpgloballearningnetwork.comCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Demystifying Reconstruction After Breast Cancer | Essence - 7 month(s) ago
Sponsored by Natrelle® Breast cancer doesn’t discriminate. It crosses all lines from socioeconomic status, to race, and more. Dr. Vivian Bea, Board-Certified General Surgeon and Chief of Breast Surgical Oncology […]
Source: www.essence.comCategories: Latest Headlines, Oncologists1Tweet
-
Mashup Score: 0Need for PrEP Support Services Persists Among Latino MSM - 7 month(s) ago
Among Latino men who have sex with men (MSM), access to and use of pre-exposure prophylaxis (PrEP) remain at suboptimal levels, despite this population of individuals having disproportionately high rates of diagnosed HIV in the United States.
Source: www.ajmc.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Clinical Solutions for Everyday Practice
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Thank you to the participants and planning committee for a great discussion addressing gaps in maternal care for patients w/ #CVD, access to comprehensive care, #HealthDisparities, contraception and risk of complications. https://t.co/dbuTy9cmKC #CardioObstretics #TransformCVCare https://t.co/livo33X1Op
-
-
Mashup Score: 0Study Results Indicate Palliative Care Less Common Among Racial Minority Patients With Metastatic Breast Cancer - 7 month(s) ago
Lack of awareness, cultural beliefs, and physician preferences may influence whether minority patients receive palliative care during metastatic breast cancer treatment.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
New research suggests that, in the United States, the use of palliative care for metastatic breast cancer varies by race.
Source: www.cancertherapyadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Patients who experience high levels of discrimination are more willing to participate in clinical trials, a survey suggests.
Source: www.cancertherapyadvisor.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
Just egregious and indefensible price gouging. This will only widen #healthdisparities. There ought to be a law... @SenatorWarnock @SenOssoff @RepNikema @POTUS @CMSGov @BrooksLaSureCMS @pfizer Pfizer to price COVID treatment Paxlovid at $1,390 per course https://t.co/ERPV7tvEPh